• Home
  • Search Results
  • Testosterone-androgen receptor: The steroid link inhibiting TRPM8-mediated cold sensitivity.

Testosterone-androgen receptor: The steroid link inhibiting TRPM8-mediated cold sensitivity.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2020-04-12)
Dimitra Gkika, Stéphane Lolignier, Guillaume P Grolez, Alexis Bavencoffe, Georges Shapovalov, Dmitri Gordienko, Artem Kondratskyi, Mathieu Meleine, Laetitia Prival, Eric Chapuy, Monique Etienne, Alain Eschalier, Yaroslav Shuba, Roman Skryma, Jérôme Busserolles, Natalia Prevarskaya

Recent studies have revealed gender differences in cold perception, and pointed to a possible direct action of testosterone (TST) on the cold-activated TRPM8 (Transient Receptor Potential Melastatin Member 8) channel. However, the mechanisms by which TST influences TRPM8-mediated sensory functions remain elusive. Here, we show that TST inhibits TRPM8-mediated mild-cold perception through the noncanonical engagement of the Androgen Receptor (AR). Castration of both male rats and mice increases sensitivity to mild cold, and this effect depends on the presence of intact TRPM8 and AR. TST in nanomolar concentrations suppresses whole-cell TRPM8-mediated currents and single-channel activity in native dorsal root ganglion (DRG) neurons and HEK293 cells co-expressing recombinant TRPM8 and AR, but not TRPM8 alone. AR cloned from rat DRGs shows no difference from standard AR. However, biochemical assays and confocal imaging reveal the presence of AR on the cell surface and its interaction with TRPM8 in response to TST, leading to an inhibition of channel activity.

Product Number
Product Description

Triton X-100, laboratory grade
Icilin, ≥97% (HPLC), solid

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.